BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 23881300)

  • 21. Value of diffusion-weighted imaging in the detection of viable tumour after neoadjuvant chemoradiation therapy in patients with locally advanced rectal cancer: comparison with T2 weighted and PET/CT imaging.
    Song I; Kim SH; Lee SJ; Choi JY; Kim MJ; Rhim H
    Br J Radiol; 2012 May; 85(1013):577-86. PubMed ID: 21343320
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ultra-high-b-value diffusion-weighted MR imaging for the detection of prostate cancer: evaluation in 201 cases with histopathological correlation.
    Katahira K; Takahara T; Kwee TC; Oda S; Suzuki Y; Morishita S; Kitani K; Hamada Y; Kitaoka M; Yamashita Y
    Eur Radiol; 2011 Jan; 21(1):188-96. PubMed ID: 20640899
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prostate cancer: utility of diffusion-weighted imaging as a marker of side-specific risk of extracapsular extension.
    Rosenkrantz AB; Chandarana H; Gilet A; Deng FM; Babb JS; Melamed J; Taneja SS
    J Magn Reson Imaging; 2013 Aug; 38(2):312-9. PubMed ID: 23238968
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of biparametric and multiparametric MRI in the diagnosis of prostate cancer.
    Xu L; Zhang G; Shi B; Liu Y; Zou T; Yan W; Xiao Y; Xue H; Feng F; Lei J; Jin Z; Sun H
    Cancer Imaging; 2019 Dec; 19(1):90. PubMed ID: 31864408
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Usefulness of prebiopsy multifunctional and morphologic MRI combined with free-to-total prostate-specific antigen ratio in the detection of prostate cancer.
    Vilanova JC; Barceló-Vidal C; Comet J; Boada M; Barceló J; Ferrer J; Albanell J
    AJR Am J Roentgenol; 2011 Jun; 196(6):W715-22. PubMed ID: 21606259
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Value of diffusion-weighted imaging for the prediction of prostate cancer location at 3T using a phased-array coil: preliminary results.
    Kim CK; Park BK; Lee HM; Kwon GY
    Invest Radiol; 2007 Dec; 42(12):842-7. PubMed ID: 18007156
    [TBL] [Abstract][Full Text] [Related]  

  • 27. High-b-value diffusion-weighted MRI for the detection of prostate cancer at 3 T.
    Wang X; Qian Y; Liu B; Cao L; Fan Y; Zhang JJ; Yu Y
    Clin Radiol; 2014 Nov; 69(11):1165-70. PubMed ID: 25182363
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prospective comparison of a fast 1.5-T biparametric with the 3.0-T multiparametric ESUR magnetic resonance imaging protocol as a triage test for men at risk of prostate cancer.
    Van Nieuwenhove S; Saussez TP; Thiry S; Trefois P; Annet L; Michoux N; Lecouvet F; Tombal B
    BJU Int; 2019 Mar; 123(3):411-420. PubMed ID: 30240059
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Optimal target b-value on computed diffusion-weighted magnetic resonance imaging for visualization of pancreatic ductal adenocarcinoma and focal autoimmune pancreatitis.
    Ichikawa S; Kromrey ML; Motosugi U; Onishi H
    Abdom Radiol (NY); 2021 Feb; 46(2):636-646. PubMed ID: 32740865
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Value of three-dimensional T2-weighted turbo spin-echo imaging with tissue-specific variable refocusing flip angle for 3-T magnetic resonance imaging of prostate cancer: comparison with conventional two- and three-dimensional T2-weighted turbo spin-echo imaging.
    Tanaka U; Ueno Y; Morinaga Y; Miyake H; Kyotani K; Ueda Y; Kitajima K; Sofue K; Suenaga Y; Sugimura K; Takahashi S
    Jpn J Radiol; 2017 Dec; 35(12):707-717. PubMed ID: 28983811
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluation of the most optimal multiparametric magnetic resonance imaging sequence for determining pathological length of capsular contact.
    Onay A; Vural M; Armutlu A; Ozel Yıldız S; Kiremit MC; Esen T; Bakır B
    Eur J Radiol; 2019 Mar; 112():192-199. PubMed ID: 30777210
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluation of Exponential ADC (eADC) and Computed DWI (cDWI) for the Detection of Prostate Cancer.
    Sprinkart AM; Marx C; Träber F; Block W; Thomas D; Schild H; Kukuk GM; Mürtz P
    Rofo; 2018 Aug; 190(8):758-766. PubMed ID: 30045400
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Non-contrast magnetic resonance imaging for bladder cancer: fused high b value diffusion-weighted imaging and T2-weighted imaging helps evaluate depth of invasion.
    Lee M; Shin SJ; Oh YT; Jung DC; Cho NH; Choi YD; Park SY
    Eur Radiol; 2017 Sep; 27(9):3752-3758. PubMed ID: 28168374
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Usefulness of diffusion-weighted imaging in the localization of prostate cancer.
    Kajihara H; Hayashida Y; Murakami R; Katahira K; Nishimura R; Hamada Y; Kitani K; Kitaoka M; Suzuki Y; Kitajima M; Hirai T; Morishita S; Awai K; Yamashita Y
    Int J Radiat Oncol Biol Phys; 2009 Jun; 74(2):399-403. PubMed ID: 19019564
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluation of Diffusion Kurtosis Imaging Versus Standard Diffusion Imaging for Detection and Grading of Peripheral Zone Prostate Cancer.
    Roethke MC; Kuder TA; Kuru TH; Fenchel M; Hadaschik BA; Laun FB; Schlemmer HP; Stieltjes B
    Invest Radiol; 2015 Aug; 50(8):483-9. PubMed ID: 25867657
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Diffusion-weighted signal models in healthy and cancerous peripheral prostate tissues: comparison of outcomes obtained at different b-values.
    Mazzoni LN; Lucarini S; Chiti S; Busoni S; Gori C; Menchi I
    J Magn Reson Imaging; 2014 Mar; 39(3):512-8. PubMed ID: 23723087
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of acquired diffusion weighted imaging and computed diffusion weighted imaging for detection of hepatic metastases.
    Shimizu H; Isoda H; Fujimoto K; Kawahara S; Furuta A; Shibata T; Togashi K
    Eur J Radiol; 2013 Mar; 82(3):453-8. PubMed ID: 23182960
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Role of diffusion weighted imaging and contrast-enhanced MRI in the evaluation of intrapelvic recurrence of gynecological malignant tumor.
    Kitajima K; Tanaka U; Ueno Y; Maeda T; Suenaga Y; Takahashi S; Deguchi M; Miyahara Y; Ebina Y; Yamada H; Tsurusaki M; Tamaki Y; Sugimura K
    PLoS One; 2015; 10(1):e0117411. PubMed ID: 25629156
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Computed diffusion-weighted imaging using 1.5-T magnetic resonance imaging for prostate cancer diagnosis.
    Yoshida R; Yoshizako T; Katsube T; Tamaki Y; Ishikawa N; Kitagaki H
    Clin Imaging; 2017; 41():78-82. PubMed ID: 27829196
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prostate cancer recurrence after radical prostatectomy: the role of 3-T diffusion imaging in multi-parametric magnetic resonance imaging.
    Panebianco V; Barchetti F; Sciarra A; Musio D; Forte V; Gentile V; Tombolini V; Catalano C
    Eur Radiol; 2013 Jun; 23(6):1745-52. PubMed ID: 23377546
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.